Company profile
Immitra Bio company profile
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful biomedical technologies: hematopoietic stem cells (HSCs) and CRISPR-Cas9 gene editing. Our novel technique allows for precise and long-lasting gene alterations within blood stem cells, resulting in transformational treatments for uncommon diseases with significant unmet medical needs.
Business identity
- Website
- https://immitrabio.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2024-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Country code
- CH
- Continent
- Europe